T1	Participants 72 111	patients with localized prostate cancer
T2	Participants 505 559	244 men with newly diagnosed localized prostate cancer
T3	Participants 871 883	participants
T4	Participants 1141 1145	EBRT
T5	Participants 1150 1175	cryoablation participants
